Company identity 1 fact
Location
Silver Spring, MD
SEC filing record 1 fact
Fiscal year end
31 December
UNITED THERAPEUTICS Corp has filed 4,224 SEC EDGAR filings since 16 Apr 1999

SEC filing history

Showing 226-250 of 1,000 matching filings.

Per page
25
Current page
10
4

PRIMARY DOCUMENT

Filing date
02 Dec 2025
Reporting date
01 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Dec 2025
Reporting date
01 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
02 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
01 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Dec 2025
Reporting date
26 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
01 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
01 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
28 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Nov 2025
Reporting date
24 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Nov 2025
Reporting date
24 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Nov 2025
Reporting date
26 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
26 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
26 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Nov 2025
Reporting date
24 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
25 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
24 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2025
Reporting date
20 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
21 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2025
Reporting date
18 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
20 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
19 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Nov 2025
Reporting date
14 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
18 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .